07.09.2016 15:00:01

DGAP-Stimmrechtsanteile: RHÖN-KLINIKUM AG

DGAP-PVR: RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

RHÖN-KLINIKUM AG

07.09.2016 15:00

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------------

Notification according to section 27a para 1 of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG)

Eugen Münch refers to his notification according to sec. 21 of the German Securities Trading Act (Wertpapierhandelsgesetz - WPHG) as of August 24, 2016 concerning the crossing of the 10% threshold of voting rights in RHÖN- KLINIKUM Aktiengesellschaft, Bad Neustadt a. d. Saale.



The crossing of this threshold in voting rights is affiliated to the initial attribution of voting rights in RHÖN-KLINIKUM Aktiengesellschaft shares which were acquired by HCM SE.

With respect to the objectives pursued with the acquisition of the voting rights, Mr. Münch has informed us pursuant to section 27a para 1 sentence 1 and 3 of the German Securities Trading Act (Wertpapierhandelsgesetz - WPHG) of the following:

1. The shareholding in RHÖN-KLINIKUM Aktiengesellschaft is unalterably assumed as a long-term strategic investment.

2. The decision to acquire or obtain in any other way further voting rights in RHÖN-KLINIKUM Aktiengesellschaft is not made yet. According to the notification of August 24, 2016 HCM SE has the opportunity to acquire another 4.38% of voting rights (2,930,000 voting rights) in RHÖN-KLINIKUM Aktiengesellschaft within the next twelve month via a forward purchase agreement.

3. The previous representation on the supervisory board of RHÖN-KLINIKUM Aktiengesellschaft should be retained unchanged. Beyond that an exertion on influence on the composition of the administration, management or supervisory boards of RHÖN-KLINIKUM Aktiengesellschaft is not intended.

4. An essential change of the capital structure, especially with regards to the ratio of internal/outside financing and dividend policy of RHÖN- KLINIKUM Aktiengesellschaft, is not intended.

The acquisition of voting rights in RHÖN-KLINIKUM Aktiengesellschaft by Eugen Münch merely took place as a consequence of the attribution of voting rights in RHÖN-KLINIKUM Aktiengesellschaft from HCM SE pursuant section 22 para 1 sentence 1 number 1 of the German Securities Trading Act (Wertpapierhandelsgesetz - WPHG). HCM SE has financed the acquisition of voting rights in RHÖN-KLINIKUM Aktiengesellschaft by approx. 88% with own funds of HCM SE as well as by approx. 12 % with external funds of HCM SE in the context of a shareholder loan provided Eugen Münch.

Bad Neustadt a. d. Saale, September 7 2016

The Board of Management

Dr. Kai G. Klinger SVP - Investor Relations, Corporate Finance and M&A RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 FAX: +49 9771 99 - 1736



07.09.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

--------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Salzburger Leite 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Analysen zu RHÖN-KLINIKUM AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

RHÖN-KLINIKUM AG 14,50 -5,23% RHÖN-KLINIKUM AG